We Are Main Street

New Research Platform Automates Clinical Trial Enrollment

Biotech operators can use the $100 monthly tool to automate data collection and shorten trial recruitment to 24 hours.

Updated on Oct. 28, 2026 in Remote Work

Isometric editorial illustration of a laboratory centrifuge, representing the automated data collection and efficiency of modern clinical trial research systems.
Alethios Inc. has launched a new automated research platform designed to streamline clinical trial recruitment, data collection, and patient management for biotech firms. AI Illustration. Upload story photo >

Live Poll

Do you trust the data collected from remote, decentralized health studies as much as clinical trials?

San Francisco-based Alethios Inc. launched a suite of decentralized research tools designed to automate participant onboarding, data collection, and device integration. The platform aims to accelerate clinical trial timelines by managing participant-reported outcomes and lab coordination remotely.

Why it matters

The platform addresses the logistical bottlenecks that often inflate research costs and extend study durations for biotech and health-tech firms. By automating administrative tasks and patient follow-ups, companies can potentially shorten trial cycles and improve data collection efficiency.

The Study Planner platform is priced at $100 per month, having facilitated five peer-reviewed papers and conference posters. In one recent saliva study, 127 of 144 participants provided usable samples, demonstrating the platform's reliability for remote data management.

The players

Alethios Inc.

A San Francisco-based developer of decentralized research data collection software for the health-tech industry.

PLT Health Solutions

A developer and marketer of science-backed ingredients for the consumer health and wellness sector.

The details

The platform utilizes a no-code integration system to manage diverse data inputs, including digital biomarkers, wearable devices, and at-home testing. It automates the operational burden of clinical research by handling participant reminders, lab coordination, compensation, and data cleaning. This structure allows researchers to conduct 12-week randomized, double-blind, placebo-controlled trials without the need for centralized site visits.

Timeline

  1. June 2026: PLT Health Solutions partnered with Alethios to offer decentralized clinical trials.

  2. Past year: The company observed seven studies enroll participants in under 24 hours.

  3. October 28, 2026: Official publication of the latest company developments.

Market Landscape

This launch follows an industry-wide trend toward adopting decentralized clinical trials to bypass traditional site-based limitations. Alethios joins a competitive field of firms attempting to standardize remote data collection and patient monitoring for the biotech sector.

Operators in the clinical research space should evaluate their current study enrollment timelines against the 24-hour benchmarks achieved via platform automation. Companies should also assess whether transitioning to a no-code data collection model could reduce overhead costs currently tied to manual laboratory coordination.

The takeaway

Decentralized platforms are increasingly capable of replacing manual administrative labor in complex, long-term clinical trials. Operators should track the conversion rates of participant-reported outcomes in their next study phase to determine if automation tools improve sample quality.

Further reading

For more on the operational shifts in distributed teams and research, visit Remote Work.

Source note: This article includes information reported by NutraIngredients.

Live Poll

Do you trust the data collected from remote, decentralized health studies as much as clinical trials?